MedTrace Logo

In Vivo Patient Preoperative Skin Prep Persistence

NCT02447497 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2024-10-02

Study results available
· View outcomes & findings →

Summary

The objective of the study is to demonstrate persistence of the CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Conditions

  • Bacterial Recovery of Skin Flora Post-Product Application

Interventions

DRUG

3M CHG/IPA Surgical Skin Preparation - Abdominal Region

Chlorhexidine gluconate 2% / Isopropyl alcohol 70%

OTHER

Normal Saline - Abdominal Region

0.9% sodium chloride applied with foam applicator

DRUG

3M CHG/IPA Surgical Skin Preparation - Inguinal Region

Chlorhexidine gluconate 2% / Isopropyl alcohol 70%

OTHER

Normal Saline - Inguinal Region

0.9% sodium chloride applied with foam applicator

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Muhammad H Bashir, MD, CCRP · MicroBioTest Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-04-30
Completion
2015-04-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02447497 on ClinicalTrials.gov